Chenghui Medical

Shenzhen Chenghui Medical Technology Co., Ltd. is an innovative molecular diagnostic company dedicated to the R&D, manufacturing, and commercialization of molecular diagnostic instruments and reagents. Built on centrifugal microfluidic technology, our fully automated multiplex Molecular POCT systems address core industry pain points: conventional nucleic acid testing relies on specialized operators and dedicated PCR laboratories. Our solutions eliminate these barriers while meeting the demand for multiplex testing across a wide range of application scenarios.


At Chenghui Medical, we are at the forefront of this diagnostic transformation with a purpose-built dual-platform strategy:

  • Multi-Disc (Model: CQ-0404): Delivers high-plex testing for severe infection diagnosis in hospital inpatient and ICU settings;

  • Flex-Disc (Model: CH-0104): Delivers rapid, flexible testing for outpatient and primary care settings via a portable design.


Core Values

请先设置数据源

CORE TEAM

Cheng Luo, Chairman
Cheng Luo, Chairman

●  Bachelor's & Master's degrees, Northwestern Polytechnical University

●  26 years of experience in the medical device manufacturing industry, with strong expertise in operations and strategic development

●  12 years of R&D and management experience at Mindray Medical


Miles Tang, General Manager
Miles Tang, General Manager

●  B.E. in Optoelectronic and Information Engineering, Nanjing University

●  Ph.D. in Biomedical Engineering, The Chinese University of Hong Kong

●  Expert in automated nucleic acid detection systems based on centrifugal microfluidics, with four publications in Lab on a Chip

 LinkedIn: Miles Tang

Hengji Cong, Technical Director
Hengji Cong, Technical Director
  • B.E. in Optoelectronic and Information Engineering, Nanjing University

  • Ph.D. in Biomedical Engineering, The Chinese University of Hong Kong

  • Postdoctoral Researcher, University College Dublin

  • Long-term focus on R&D of microfluidics and molecular diagnostic technologies, with more than ten papers published in international journals including Biosensors and Bioelectronics and Sensors and Actuators B: Chemical

  • LinkedIn: Hengji CONG


NEWS & BLOGS

Global Infectious Disease Diagnostics: Why One-Size-Fits-All Solutions Fail Across Markets
Infectious diseases remain a defining pressure on global healthcare systems — yet the diagnostic land...

View details+

Global Molecular POCT: How Syndromic Testing & Decentralized Care Are Redefining Diagnostic Standards
【Industry Insights】Lab-quality molecular diagnostic results in 30 minutes — no centralized lab, no sp...

View details+

The Value of Multiplex Pathogen Detection: Stop Guessing, Start Diagnosing Precisely
Is your clinic still relying on the "test-and-wait" game for acute infections?Fever, cough, diarrhea—...

View details+

Molecular POCT vs. Traditional Lab PCR
Traditional lab PCR has long been the gold standard in molecular diagnostics — yet its inherent bottl...

View details+

Why Molecular POCT Is the Next Breakthrough in Global Infectious Disease Diagnosis?
Global infectious disease diagnosis has long been constrained by two fundamental gaps that limit time...

View details+